Author:
Murlanova Kateryna,Cohen Netanela,Pinkus Anna,Vinnikova Liudmila,Pletnikov Mikhail,Kirby Michael,Gorelick Jonathan,Drori Elyashiv,Pinhasov Albert
Abstract
AbstractDittrichia viscosa is a perennial Mediterranean plant used in traditional medicine for “calming purposes”, pointing at a possible antidepressant activity of the plant. We conducted chromatographic and bioassay-guided fractionation of D. viscosa root extract to isolate a specific fraction (fraction “K”) with antidepressant-like characteristics in vivo and strong antioxidant properties in vitro. A single dose of “K” reduced immobility time in the forced swim test with a mouse model possessing a depressive-like phenotype. Neurochemical profiling for 5-hydroxytryptamine (5-HT) and its primary metabolite, 5-hydroxyindoleacetic acid (5-HIAA), in prefrontal cortex and hippocampus of “K”-treated mice showed reduction in 5-HIAA, indicative of either serotonin uptake transporter or monoamine oxidase-A inhibition, as well as slight increases in 5-HT content. These neurochemical alterations, as well as the behavioral changes observed, were comparable to the effects of paroxetine. “K” also protected PC12 cells in a H2O2 cytotoxicity assay, thus demonstrating antioxidant properties, yet paroxetine augmented oxidative damage and cell death. Identification of the main compounds in “K” by high-performance liquid chromatography-tandem mass spectrometry (HPLC–MS/MS) indicated that chlorogenic acid and cynarine comprised 87% of the total components. D. viscosa root extract appears to produce antidepressant and cytoprotective effects and may serve as an attractive alternative to standard therapies for depression.
Funder
Israel ministry of science, tech
Publisher
Springer Science and Business Media LLC
Reference61 articles.
1. World Health Organization, Depression and Other Common Mental Disorders: Global Health Estimates. 2017, World Health Organization; Licence: CC BY-NC-SA 3.0 IGO.
2. Friedrich, M. J. Depression is the leading cause of disability around the world. JAMA 317(15), 1517–1517 (2017).
3. Hillhouse, T. M. & Porter, J. H. A brief history of the development of antidepressant drugs: From monoamines to glutamate. Exp. Clin. Psychopharmacol. 23(1), 1–21 (2015).
4. El-Hage, W. et al. Mechanisms of antidepressant resistance. Front Pharmacol. 4, 146 (2013).
5. Ekor, M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 4, 177 (2014).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献